(Q35618115)

9 August 2017

1 reference

title

Dendritic cells: a journey from laboratory to clinic (English)

1 reference

9 August 2017

1 reference

Ian F Hermans

0 references

Mariolina Salio

0 references

Vincenzo Cerundolo

0 references

language of work or name

English

0 references

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

7-10

1 reference

Dendritic cells and the control of immunity

9 August 2017

cites work

1 reference

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

7 January 2021

The use of dendritic cells in cancer immunotherapy

1 reference

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

7 January 2021

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

7 January 2021

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

7 January 2021

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

1 reference

7 January 2021

In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells

1 reference

7 January 2021

Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses

1 reference

7 January 2021

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

1 reference

7 January 2021

Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

1 reference

7 January 2021

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

7 January 2021

Progressive differentiation and selection of the fittest in the immune response

1 reference

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

7 January 2021

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

1 reference

7 January 2021

Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols

1 reference

7 January 2021

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

1 reference

7 January 2021

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming

1 reference

7 January 2021

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity

1 reference

7 January 2021

Identifiers

DOI

10.1038/NI0104-7

1 reference

Dimensions Publication ID

9 August 2017

1006139681

0 references

1 reference